Evidence map›Paper›PMID 33114749›Full record

ArticleTropical medicine and infectious disease2020

The TB REACH Initiative: Supporting TB Elimination Efforts in the Asia-Pacific.

Jacob Creswell, Amera Khan, Mirjam I Bakker, Miranda Brouwer, Vishnu Vardhan Kamineni, Christina Mergenthaler, Marina Smelyanskaya, Zhi Zhen Qin, Oriol Ramis, Robert Stevens and 2 more

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jacob CreswellStop TB Partnership, 1218 Geneva, Switzerland.ORCID 0000-0002-4885-940X
Amera KhanStop TB Partnership, 1218 Geneva, Switzerland.ORCID 0000-0002-4052-2028
Mirjam I BakkerKIT Royal Tropical Institute, 1092 Amsterdam, The Netherlands.ORCID 0000-0002-5104-3727
Miranda BrouwerPHTB Consult, 5014 DN Tilburg, The Netherlands.
Vishnu Vardhan KamineniIndependent Consultant, Bangalore 560094, India.
Christina MergenthalerKIT Royal Tropical Institute, 1092 Amsterdam, The Netherlands.ORCID 0000-0001-9936-9446
Marina SmelyanskayaStop TB Partnership, 1218 Geneva, Switzerland.
Zhi Zhen QinStop TB Partnership, 1218 Geneva, Switzerland.
Oriol RamisEpirus, 08034 Barcelona, Spain.ORCID 0000-0003-0607-3713
Robert StevensIndependent Consultant, Manchester HX7 6AL, UK.
K Srikanth ReddyGlobal Affairs Canada, Global Health and Nutrition Bureau, Ottawa K1A 0G2, ON, Canada.
Lucie BlokKIT Royal Tropical Institute, 1092 Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After many years of TB 'control' and incremental progress, the TB community is talking about ending the disease, yet this will only be possible with a shift in the way we approach the TB response. While the Asia-Pacific region has the highest TB burden worldwide, it also has the opportunity to lead the quest to end TB by embracing the four areas laid out in this series: using data to target hotspots, initiating active case finding, provisioning preventive TB treatment, and employing a biosocial approach. The Stop TB Partnership's TB REACH initiative provides a platform to support partners in the development, evaluation and scale-up of new and innovative technologies and approaches to advance TB programs. We present several approaches TB REACH is taking to support its partners in the Asia-Pacific and globally to advance our collective response to end TB.

Indexed as

active case findingEnd TBinnovationTB preventive therapyTB REACHtuberculosis

Identifiers

PMID33114749
PMCPMC7709586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.